Skip to Content

User Reviews for Lofibra

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Learn more about Lofibra.

Condition	Reviews	Compare	Avg. Ratings

Reviews for Lofibra

No reviews have yet been submitted. Be the first to review this drug.

Learn more about

Drugs.com Health Center:

Cholesterol

More about Lofibra (fenofibrate)

Consumer resources

Other brands: TriCor, Lipofen, Antara, Triglide, More (1) »

Professional resources

Related treatment guides

Drug Status

Availability Rx Prescription only

Pregnancy Category C Risk cannot be ruled out

CSA Schedule N Not a controlled drug

High Cholesterol

FDA Consumer Updates

More FDA updates

Drug Class

Fibric acid derivatives

Recently Approved

Amjevita Amjevita (adalimumab-atto) is biosimilar to Humira, an anti-TNF-α monoclonal antibody approved for ...
Exondys 51 Exondys 51 (eteplirsen) is an antisense oligonucleotide indicated for the treatment of Duchenne...
Kyleena Kyleena (levonorgestrel-releasing intrauterine system) is a low-dose progestin-containing...
Yosprala Yosprala (aspirin and omeprazole) is a platelet aggregation inhibitor and proton pump inhibitor...

Lofibra Images

Lofibra 54 mg

Lofibra (fenofibrate) 54 mg

Related News and Articles

How Long Will You Live? Look to Your Parents August 15, 2016
Stroke Hospitalization Down for Many in U.S. May 11, 2016
Statins Might Protect People With Narrowed Leg Arteries May 6, 2016

Related Questions & Answers

Read more questions...

Drugs.com Discount Card

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Sep 2nd, 2016), Cerner Multum™ (updated Sep 5th, 2016), Wolters Kluwer™ (updated Aug 8th, 2016) and others. To view content sources and attributions, please refer to our editorial policy.